These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation. Chu WW; Torguson R; Pichard AD; Satler LF; Chan R; Porrazzo M; Kent KM; Suddath WO; Waksman R J Invasive Cardiol; 2005 Dec; 17(12):659-62. PubMed ID: 16327049 [TBL] [Abstract][Full Text] [Related]
4. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis. Torguson R; Sabate M; Deible R; Smith K; Chu WW; Kent KM; Pichard AD; Suddath WO; Satler LF; Waksman R Am J Cardiol; 2006 Nov; 98(10):1340-4. PubMed ID: 17134625 [TBL] [Abstract][Full Text] [Related]
5. Vascular brachytherapy for patients with drug-eluting stent restenosis. Bonello L; Kaneshige K; De Labriolle A; Roy P; Lemesle G; Torguson R; Satler LF; Pichard AD; Lindsay J; Waksman R J Interv Cardiol; 2008 Dec; 21(6):528-34. PubMed ID: 18973502 [TBL] [Abstract][Full Text] [Related]
6. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Ellis SG; O'Shaughnessy CD; Martin SL; Kent K; McGarry T; Turco MA; Kereiakes DJ; Popma JJ; Friedman M; Koglin J; Stone GW; Eur Heart J; 2008 Jul; 29(13):1625-34. PubMed ID: 18556716 [TBL] [Abstract][Full Text] [Related]
7. Five-year clinical follow up after intracoronary radiation for the prevention of in-stent restenosis. Gruberg L; Caiati R; Aronson D; Suleiman M; Petchersky S; Nikolsky E; Grenadier E; Boulus M; Markiewicz W; Kerner A; Beyar R J Invasive Cardiol; 2006 Oct; 18(10):494-8. PubMed ID: 17042094 [TBL] [Abstract][Full Text] [Related]
8. Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial. Kaneda H; Honda Y; Morino Y; Lansky AJ; Yock PG; Bonan R; Fitzgerald PJ J Interv Cardiol; 2006 Oct; 19(5):376-80. PubMed ID: 17020560 [TBL] [Abstract][Full Text] [Related]
9. Poor outcome in patients treated with brachytherapy for diffuse in-stent restenosis. The role of additional stenting despite prolonged antiplatelet therapy. Zavalloni D; Rossi M; Belli G; Scatturin M; Morenghi E; Marsico F; Catalano G; Tosi G; Pagnotta P; Presbitero P J Invasive Cardiol; 2005 Nov; 17(11):598-602. PubMed ID: 16264205 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Patients With Recurrent Coronary In-stent Restenosis With Failed Intravascular Brachytherapy. Yerasi C; Chen Y; Case BC; Forrestal BJ; Shea C; Zhang C; Torguson R; Ben-Dor I; Satler LF; Waksman R Am J Cardiol; 2021 Mar; 142():44-51. PubMed ID: 33285089 [TBL] [Abstract][Full Text] [Related]
11. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011 [TBL] [Abstract][Full Text] [Related]
13. Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial. Ribichini F; Ferrero V; Piessens M; Heyndrickx GR; de Bruyne B; Verbeke L; Matullo G; Büchi M; Piazza A; Guarrera S; Lüscher TF; Wijns W Cardiovasc Revasc Med; 2005; 6(1):7-13. PubMed ID: 16263350 [TBL] [Abstract][Full Text] [Related]
14. Alpha particle vascular brachytherapy in the treatment of in-stent Restenosis. Mehdizadeh A; Fazelzadeh A; Karimi H Int J Cardiol; 2009 Aug; 136(2):220-1. PubMed ID: 18625530 [TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome of patients treated with beta-brachytherapy in routine clinical practice. Nikas DN; Kalef-Ezra J; Katsouras CS; Tsekeris P; Bozios G; Pappas C; Naka KK; Kotsia A; Papamichael N; Sideris DA; Michalis LK Int J Cardiol; 2007 Feb; 115(2):183-9. PubMed ID: 16890309 [TBL] [Abstract][Full Text] [Related]
16. Clinical results of intracoronary brachytherapy (ICBT) for multiple in-stent restenosis. Stadler P; Schäfer C; Chaber S; Putnik K; Treutwein M; Koelbl O; Muders F Strahlenther Onkol; 2006 Jun; 182(6):312-7. PubMed ID: 16703285 [TBL] [Abstract][Full Text] [Related]
17. Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intracoronary brachytherapy for the treatment of in-stent restenosis. Fasseas P; Orford JL; Lennon R; O'Neill J; Denktas AE; Panetta CJ; Berger PB; Holmes DR Catheter Cardiovasc Interv; 2004 Oct; 63(2):152-7. PubMed ID: 15390249 [TBL] [Abstract][Full Text] [Related]
18. Intracoronary brachytherapy for in-stent restenosis using long sources reduces restenosis. Bagga R; Kini A; Lee P; Agarwal A; Duffy M; Kim M; Sharma S J Invasive Cardiol; 2005 Jun; 17(6):302-6. PubMed ID: 16003004 [TBL] [Abstract][Full Text] [Related]
19. Intracoronary radiation therapy using a novel beta emitter for in-stent restenosis Tungsten WRIST. Dilcher C; Satler LF; Pichard AD; Kent KM; Porrazzo M; Chan R; Torguson R; Canos DA; Waksman R Cardiovasc Revasc Med; 2005; 6(2):52-7. PubMed ID: 16263359 [TBL] [Abstract][Full Text] [Related]
20. An intravascular ultrasound analysis of the mechanisms of restenosis comparing drug-eluting stents with brachytherapy. Kim SW; Mintz GS; Escolar E; Ohlmann P; Pregowski J; Tyczynski P; Hassani SE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R; Weissman NJ Am J Cardiol; 2006 May; 97(9):1292-8. PubMed ID: 16635598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]